Thank you, Mr. Chair.
Being new to this committee, I certainly find it very interesting. But something has percolated to the surface here and I can certainly understand that.
I want to thank Ms. Binder for her directness on the question in regard to funding. Some may have felt it should have been disclosed beforehand. I didn't see any reservation on your part in responding, and I appreciate that. And I can understand that a person who has difficulties in their life would feel an alignment to some extent with pharmaceutical companies who supply the benefits to them. I think that's perfectly reasonable.
I would be curious, though, if any of the presenters have any association or receive funding from the pharmaceutical companies, just in fairness.
Ms. Fowler.